CF33-hNIS-antiPDL1. *moves mouse to x button to close tab* “But wait!” your writer screams from the page, “I promise it’s interesting!” Whilst I may not have the teaching prowess of Ms Frizzle, I implore you to stick around, because Imugene’s (ASX: IMU) immuno-oncology stuff is really interesting once you wrap your head around it. The
Read More
There is never a dull moment in financial markets. U.S. Phase-One Trade Deal It has been reported U.S. President Donald Trump has signed off on a phase-one deal, which will importantly prevent additional tariffs being introduced on 15 December on approximately $160bn consumer goods. From our perspective, its 13 Dec-19 and something had to be announced
Read More
Some would argue the absurd remuneration of top level company managers is the root cause of many of the economic issues we are seeing today. But data shows just how out of hand it has become. Using a ratio that compares wages of the average CEO versus the average unskilled worker, a study from 2014
Read More
Section 1: The Market Research A survey of 500 Australians from all across the country has identified an area of healthcare where Australians are not looking after themselves. The findings identified a common trend amongst participants who were not aware of the services a podiatrist offered, despite experiencing pain in their lower legs and feet.
Read More